SCHEMBL25827157

SCHEMBL25827157

O=C(c1cccc(Nc2ccncc2)c1)N1CCc2c(Oc3ccncc3)cccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 5/20 0.40
HTR2A P28223 2/20 0.40
UCHL1 P09936 1/20 0.40
NOTUM Q6P988 1/20 0.40
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
STAT3 P40763 1/20 0.38
GAA P10253 1/20 0.38
HTT P42858 1/20 0.38
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HTR2B P41595 1/20 0.37
TP53 P04637 1/20 0.37
PDCD1 Q15116 3/20 0.37
CD274 Q9NZQ7 3/20 0.37
MET P08581 1/20 0.37
GPBAR1 Q8TDU6 1/20 0.36
MEN1 O00255 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25820804 0.96 UCHL1 (0.45) HTR2CHTR2AUCHL1NOTUMCYP11B1
SCHEMBL24010364 0.92 HTR2C (0.39) HTR2CHTR2AUCHL1NOTUMCYP11B1
SCHEMBL25827158 0.87 UCHL1 (0.38) HTR2CHTR2AUCHL1NOTUMSMN1; SMN2
SCHEMBL25820818 0.85 UCHL1 (0.42) HTR2CUCHL1NOTUMCYP11B1CYP11B2
SCHEMBL25820801 0.84 UCHL1 (0.43) HTR2CUCHL1NOTUMTSHRSMN1; SMN2
SCHEMBL25488283 0.83 GAK (0.40) GAAHTTMETRAF1
SCHEMBL25488381 0.83 GSK3B (0.34) HTR2CHTR2AUCHL1CYP11B1CYP11B2
SCHEMBL24010367 0.83 STAT3 (0.42) HTR2CHTR2ACYP11B1CYP11B2STAT3
SCHEMBL24010363 0.82 HTR2C (0.38) HTR2CHTR2AUCHL1NOTUMSMN1; SMN2
SCHEMBL25488284 0.81 ALDH1A1 (0.46) GAAHTTTSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA HTR2C 2111/4885HTR2A 2539/4885UCHL1 4725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.